F. Edward Boas, MD, PhD

About Me

As an interventional radiologist, I perform minimally invasive procedures using needles and catheters, providing an alternative to surgery for many patients. I can guide a needle or a catheter toward a tumor using CT, ultrasound, or x-ray, then burn or freeze the tumor (ablation), block its blood supply (embolization), or implant microscopic radioactive particles to treat it (radioembolization). These procedures can be used to treat cancer in the lung, liver, and kidney. I can also reopen blood vessels that are blocked or narrowed by a blood clot or a tumor using minimally invasive techniques that are performed through a catheter.

I have done thousands of image-guided procedures and use a multidisciplinary clinical approach, which involves coordinating care with surgeons, oncologists, and other specialists to decide the best treatment strategy for each patient. I teach other doctors how to perform these procedures at national meetings, and I am a reviewer for several medical journals.

My research focuses on developing new minimally invasive methods for treating liver, pancreatic, and kidney cancer.  We have some promising results in the laboratory on how to improve the safety and efficacy of tumor embolization and ablation, which we plan to translate into human clinical trials in the next few years

  • Clinical Expertise: Tumor ablation and embolization; Radioembolization of liver tumors; DVT treatment; Portal hypertension
  • Languages Spoken: English
  • Education: MD, PhD, Stanford University
  • Residencies: Stanford Hospital
  • Fellowships: Hospital of the University of Pennsylvania
  • Board Certifications: Diagnostic Radiology

My Research

Microscope iconAn icon showing a microscope. View my lab Arrow rightAn icon showing an arrow pointing to the right.

See F. Edward Boas’ laboratory
research at Memorial Sloan Kettering.


Visit PubMed for a full listing of F. Edward Boas’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.